Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pietro Medio

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Aging Clinical and Experimental Research|March 17, 2022
Reliability of fr-AGILE tool to evaluate multidimensional frailty in hospital settings for older adults with COVID-19Francesco Curcio, Alessio De Vita, Gerardo Gerundo, et al.
Respiratory Medicine|October 21, 2021
Effectiveness and safety of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease with the Phe508del/minimal function genotypeVincenzo Carnovale, Paola Iacotucci, Vito Terlizzi, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Aging Clinical and Experimental Research|March 17, 2022
Reliability of fr-AGILE tool to evaluate multidimensional frailty in hospital settings for older adults with COVID-19Francesco Curcio, Alessio De Vita, Gerardo Gerundo, et al.
Respiratory Medicine|October 21, 2021
Effectiveness and safety of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease with the Phe508del/minimal function genotypeVincenzo Carnovale, Paola Iacotucci, Vito Terlizzi, et al.
Pageof 1